"10.1371_journal.pone.0087382","plos one","2014-01-31T00:00:00Z","Michael B Rothberg; Penelope S Pekow; Aruna Priya; Marya D Zilberberg; Raquel Belforti; Daniel Skiest; Tara Lagu; Thomas L Higgins; Peter K Lindenauer","Department of Medicine, Medicine Institute, Cleveland Clinic, Cleveland, Ohio, United States of America; Division of General Medicine, Baystate Medical Center, Springfield, Massachusetts, United States of America; Center for Quality of Care Research, Baystate Medical Center, Springfield, Massachusetts, United States of America; Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America; University of Massachusetts Amherst, Amherst, Massachusetts, United States of America; EviMed Research Group, LLC, Goshen, Massachusetts, United States of America; Division of Infectious Diseases, Baystate Medical Center, Springfield, Massachusetts, United States of America; Division of Pulmonary and Critical Care, Baystate Medical Center, Springfield, Massachusetts, United States of America","Conceived and designed the experiments: MBR PSP AP MZ RB DS TL TH PKL. Performed the experiments: MBR PSP AP. Analyzed the data: MBR PSP AP MZ RB DS TL TH PKL. Wrote the paper: MBR AP PSP. Critical revision of the manuscript for important intellectual content: PSP AP MZ RB DS TL TH PKL.","The authors have the following interests: Dr. Marya D. Zilberberg is employed by EviMed Research Group, LLC. Dr. Zilberberg has received research funding and served as a consultant for Pfizer, Astellas, Cubist, Forest, and Johnson and Johnson. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","01","Michael B Rothberg","MBR",9,TRUE,9,3,9,3,TRUE,TRUE,FALSE,0,NA,FALSE
